A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 19,685 shares of ATRC stock, worth $729,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,685
Previous 40,317 51.17%
Holding current value
$729,526
Previous $918,000 39.98%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$20.34 - $29.5 $419,654 - $608,644
-20,632 Reduced 51.17%
19,685 $551,000
Q2 2024

Aug 14, 2024

SELL
$19.86 - $29.09 $113,043 - $165,580
-5,692 Reduced 12.37%
40,317 $918,000
Q1 2024

May 14, 2024

BUY
$28.21 - $37.78 $721,583 - $966,374
25,579 Added 125.2%
46,009 $1.4 Million
Q4 2023

Feb 14, 2024

SELL
$32.99 - $43.25 $50,045 - $65,610
-1,517 Reduced 6.91%
20,430 $729,000
Q3 2023

Nov 13, 2023

SELL
$41.12 - $57.73 $1.59 Million - $2.24 Million
-38,723 Reduced 63.83%
21,947 $961,000
Q2 2023

Aug 11, 2023

SELL
$40.44 - $49.6 $189,097 - $231,929
-4,676 Reduced 7.16%
60,670 $2.99 Million
Q1 2023

May 12, 2023

BUY
$35.87 - $47.22 $420,826 - $553,985
11,732 Added 21.88%
65,346 $2.71 Million
Q4 2022

Feb 13, 2023

SELL
$33.48 - $47.45 $610,943 - $865,867
-18,248 Reduced 25.39%
53,614 $2.38 Million
Q3 2022

Nov 10, 2022

BUY
$38.25 - $52.62 $3,557 - $4,893
93 Added 0.13%
71,862 $2.81 Million
Q2 2022

Aug 11, 2022

BUY
$35.1 - $66.01 $245,103 - $460,947
6,983 Added 10.78%
71,769 $2.93 Million
Q1 2022

May 13, 2022

BUY
$57.43 - $71.39 $914,859 - $1.14 Million
15,930 Added 32.61%
64,786 $4.25 Million
Q4 2021

Feb 14, 2022

BUY
$63.4 - $87.14 $439,108 - $603,531
6,926 Added 16.52%
48,856 $3.4 Million
Q3 2021

Nov 12, 2021

SELL
$69.28 - $84.46 $103,504 - $126,183
-1,494 Reduced 3.44%
41,930 $2.92 Million
Q2 2021

Aug 13, 2021

BUY
$64.13 - $80.18 $2.78 Million - $3.48 Million
43,424 New
43,424 $3.45 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.72B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.